Case histories of peptidomimetics: Progression from peptides to drugs
- 1 January 1994
- journal article
- review article
- Published by Wiley in Recueil des Travaux Chimiques des Pays-Bas
- Vol. 113 (2) , 63-78
- https://doi.org/10.1002/recl.19941130202
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Biochemistry and Genetic Engineering of HirudinSeminars in Thrombosis and Hemostasis, 1989
- Antithrombin properties of C‐terminus of hirudin using synthetic unsulfated Nα‐acetyl‐hirudin45–65FEBS Letters, 1987
- Ketomethylene pseudopeptide analogs of substance P: synthesis and biological activityJournal of Medicinal Chemistry, 1986
- Conformationally restricted inhibitors of angiotensin-converting enzyme. Synthesis and computationsJournal of Medicinal Chemistry, 1986
- Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statineJournal of Medicinal Chemistry, 1985
- Are the proposed substance P receptor sub-types, substance P receptors?Life Sciences, 1984
- Structure-activity studies on the C-terminal amide of substance PJournal of Medicinal Chemistry, 1982
- Conformational restrictions of biologically active peptides via amino acid side chain groupsLife Sciences, 1982
- Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venomCellular and Molecular Life Sciences, 1973